Search

everythinglearnresearchcommunity

for

Search:↓

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Letrozole with lifestyle changes improves fertility in women with PCOS.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

USPlus PRO saw palmetto extract improves urinary symptoms and is safe for men.

Isoflavones may help with menopause symptoms but could be risky for women with hormone-sensitive cancers.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Clascoterone is safe for the heart, even at high doses.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Ondansetron can cause serious allergic reactions, so use it carefully.

Efalizumab can cause unexpected excessive hair growth.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

New drug uses show promise but need more research.

Ruxolitinib can help regrow hair in severe alopecia areata.

The study successfully formulated and optimized a bilayer tablet combining Tamsulosin and Finasteride using response surface methodology.

Minoxidil effectively lowers blood pressure with few side effects.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Clascoterone cream 1% is effective and well-tolerated for treating acne and other related conditions.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.